Monitor for HCR Molag's potential sale of up to 400,000 shares which could create downward pressure on stock price. The minimal proceeds to Atara ($40) suggest this is not a capital raise but rather facilitating an investor exit. Watch for warrant exercise which would provide nominal cash but increase share count.
ATRA drugs
ATRA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 18 $5.00entry
- T+1 · 8mo ago +2.40%α +2.67% · $5.12
- T+5 · 8mo ago −0.80%α −0.09% · $4.96
- T+20 · 7mo ago +4.80%α −1.25% · $5.24
- T+60 · 5mo ago +109.20%α +97.67% · $10.46
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Atara Biotherapeutics has filed an S-3 shelf registration to register 400,000 shares of common stock for resale by HCR Molag Fund, L.P., a selling stockholder. These shares are issuable upon exercise of a warrant granted in connection with an amendment to a purchase agreement that extended the due date of a $9.0 million milestone payment from June 2026 to January 2028. Atara will not receive proceeds from the resale, but may receive $0.04 from the warrant exercise. The offering represents a 4.9% dilution based on current market cap.
Key Financial Metrics
Key Facts
- S-3 filing registers 400,000 shares for resale by HCR Molag Fund, L.P.
- Shares are issuable upon exercise of a warrant with $0.0001 exercise price.
- Warrant was issued in connection with extending a $9.0 million milestone payment due date from June 2026 to January 2028.
- Atara will not receive proceeds from the resale of shares by the selling stockholder.
- Atara may receive $40 from warrant exercise (400,000 shares × $0.0001).
- Offering represents 4.9% of current shares outstanding (8.178M).
- Current market cap is $42M with stock price at $6.50.
Financial Impact
Potential $40 in proceeds to Atara from warrant exercise; 4.9% potential dilution from resale
Risk Factors
- Potential stock price pressure from HCR Molag selling up to 400,000 shares
- Dilution of existing shareholders if warrant is exercised and shares are sold
- Market perception of insider selling despite being a contractual obligation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001193125-26-110849 |
| Document: d100379dexfilingfees.htm | 0001193125-26-110849 |
| Document: d100379dex51.htm | 0001193125-26-110849 |
| Document: d100379dex231.htm | 0001193125-26-110849 |
| Document: 0001193125-26-110849-index-headers.html | 0001193125-26-110849 |
| Document: 0001193125-26-110849-index.html | 0001193125-26-110849 |
| Document: 0001193125-26-110849.txt | 0001193125-26-110849 |
| CONTEXT: 10-Q (2025-11-12) | 0001193125-25-276219 |
Track record
11 reports on ATRA
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 20266d ago S-3 Bearish 5/10 Entry $8.23 to $7.93 Now $6.40 +22.24% ▲ +3.65% +3.29% vs SPY
- Nov 10, 20266d ago 8-K Neutral 5/10 Entry $8.23 to $7.93 Now $6.40 −22.24% ▼ −3.65% −3.29% vs SPY
- Jun 26, 202620w ago 8-K Neutral 3/10 Entry $11.17 to $11.48 Now $6.40 −42.70% ▲ +2.78% +2.00% vs SPY
- Jun 15, 202622w ago 3 Neutral 2/10 Entry $9.62 to $9.67 Now $6.40 −33.47% ▲ +0.52% +1.77% vs SPY
- May 7, 202627w ago 8-K Neutral 4/10 Entry $9.93 to $8.34 Now $6.40 −35.55% ▼ −16.01% −16.84% vs SPY
- May 7, 202627w ago Insider Cluster Mixed 5/10 Entry $9.93 to $8.34 Now $6.40 −35.55% ▼ −16.01% −16.84% vs SPY
- Apr 24, 202629w ago DEFA14A Neutral 3/10 Entry $4.99 to $4.73 Now $6.40 +28.26% ▼ −5.21% −4.73% vs SPY
- Mar 17, 202634w ago S-3 Neutral 4/10 Viewing Entry $5.00 to $5.12 Now $6.40 +28.00% ▲ +2.40% +2.67% vs SPY
- Mar 12, 202635w ago 8-K Neutral 5/10 Entry $6.90 to $6.50 Now $6.40 −7.25% ▼ −5.80% −5.20% vs SPY
- Mar 3, 202636w ago 8-K Mixed 6/10 Entry $5.42 to $5.39 Now $6.40 +18.08% ▼ −0.55% −1.31% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers